A008930 Share Price Performance
₩36,750.00
3750.00 (11.36%)
Price ₩36,750.00
Share Price₩36,750.00
Hanmi Science's (KRX:008930) Returns On Capital Are Heading Higher
Oct 13
Hanmi Science Co., Ltd. Stock Price
- 0 Narratives written by author
- 0 Comments on narratives written by author
- 0 Fair Values set on narratives written by author
A008930 Community Narratives
There are no narratives available yet.
Recent A008930 News & Updates
Does Hanmi Science (KRX:008930) Have A Healthy Balance Sheet?
Aug 20What Hanmi Science Co., Ltd.'s (KRX:008930) 29% Share Price Gain Is Not Telling You
Jul 15Returns At Hanmi Science (KRX:008930) Are On The Way Up
Jul 10Hanmi Science Co., Ltd.'s (KRX:008930) 30% Share Price Surge Not Quite Adding Up
May 16Hanmi Science (KRX:008930) Has A Pretty Healthy Balance Sheet
May 09Hanmi Science Co., Ltd. Key Details
Last Reported Earnings
Jun 30, 2025
Next Reporting Earnings
n/a
- Earnings per share (EPS)
- 895.61
- Gross Margin
- 21.27%
- Net Profit Margin
- 4.58%
- Debt/Equity Ratio
- 24.4%
Hanmi Science Co., Ltd. Competitors
Snowflake Analysis
About A008930
- Founded
- 1973
- Employees
- 476
- CEO
- WebsiteView website
Hanmi Science Co., Ltd., through its subsidiaries, manufactures and sells pharmaceutical products in Korea and internationally. It develops drugs in the areas of diabetes and anti-cancer, as well as children's and adult’s bowel preparation and cold medicines, and cephalosporin antibiotics. The company also offers general foods, health functional foods, soy milk, and medical equipment. In addition, it offers automated drug management systems. The company sells its products through online and offline pharmacies. The company was formerly known as Hanmi Holdings Co., Ltd. and changed its name to Hanmi Science Co., Ltd. in March 2012. Hanmi Science Co., Ltd. was founded in 1973 and is headquartered in Seoul, South Korea.
Market Insight
Q4 2025 is off to a flying start with record highs being printed left, right, and center. US and Japanese stocks made fresh new highs, while the gold price powered through $4,000 for the first time, and Bitcoin crossed the $126k level. Is this all a case of USD weakness, irrational exuberance, or solid fundamentals? This week, we are reviewing Q3 market performance, Q2 earnings season, and the outlook heading into the end of 2025…
Continue reading
South Korean Market Performance
- 7 Days: 0.2%
- 3 Months: 11.3%
- 1 Year: 31.8%
- Year to Date: 44.9%
Over the last 7 days, the market has remained flat, although notably the Materials sector gained 6.4% in that time. As for the longer term, the market has risen 32% in the past 12 months. As for the next few years, earnings are expected to grow by 25% per annum. Market details ›